Evidence for upregulated repair of oxidatively induced DNA damage in human colorectal cancer

DNA Repair

Volumn 10, Issue 11, 2011, Pages 1114-1120

  Kirkali, Güldal ^a   Keles, Didem ^a   Canda, Aras E ^a   Terzi, Cem ^a   Reddy, Prasad T ^b   Jaruga, Pawel ^b   Dizdaroglu, Miral ^b   Oktay, Gülgün ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Colorectal cancer; DNA lesions; DNA repair; Free radicals; Hydroxyl radical; Oxidatively induced DNA damage

Indexed keywords

2,6 DIAMINO 4 HYDROXY 5 FORMAMIDOPYRIMIDINE; 4,6 DIAMINO 5 FORMAMIDOPYRIMIDINE; 8 HYDROXYGUANINE; 8,5' CYCLO 2' DEOXYADENOSINE; DEOXYADENOSINE DERIVATIVE; DNA BASE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; FEMALE; GAS CHROMATOGRAPHY; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UPREGULATION;

ADULT; AGED; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; DEOXYADENOSINES; DNA DAMAGE; DNA REPAIR; FEMALE; GUANINE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; OXIDATION-REDUCTION; PYRIMIDINES; UP-REGULATION;

EID: 80054728008     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.08.008     Document Type: Article

References (79)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007, 18:581-592.
2. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
3. Bosken C.H., Wei Q., Amos C.I., Spitz M.R. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J. Natl. Cancer Inst. 2002, 94:1091-1099.
4. Rosell R., Taron M., Barnadas A., Scagliotti G., Sarries C., Roig B. Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer. Cancer Control 2003, 10:297-305.
5. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
6. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
7. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat. Rev. Cancer 2004, 4:769-780.
8. Santarelli R.L., Pierre F., Corpet D.E. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer 2008, 60:131-144.
9. Nomura A.M., Wilkens L.R., Murphy S.P., Hankin J.H., Henderson B.E., Pike M.C., Kolonel L.N. Association of vegetable, fruit, and grain intakes with colorectal cancer: the multiethnic cohort study. Am. J. Clin. Nutr. 2008, 88:730-737.
10. Sansbury L.B., Wanke K., Albert P.S., Kahle L., Schatzkin A., Lanza E. The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence. Am. J. Epidemiol. 2009, 170:576-584.
11. Gackowski D., Banaszkiewicz Z., Rozalski R., Jawien A., Olinski R. Persistent oxidative stress in colorectal carcinoma patients. Int. J. Cancer 2002, 101:395-397.
12. Goodman M., Bostick R.M., Dash C., Terry P., Flanders W.D., Mandel J. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas. Cancer Causes Control 2008, 19:1051-1064.
13. Leung E.Y., Crozier J.E., Talwar D., O'Reilly D.S., McKee R.F., Horgan P.G., McMillan D.C. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int. J. Cancer 2008, 123:2460-2464.
14. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
15. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
16. Meira L.B., Bugni J.M., Green S.L., Lee C.W., Pang B., Borenshtein D., Rickman B.H., Rogers A.B., Moroski-Erkul C.A., McFaline J.L., Schauer D.B., Dedon P.C., Fox J.G., Samson L.D. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 2008, 118:2516-2525.
17. Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567:1-61.
18. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC.
19. Cheadle J.P., Dolwani S., Sampson J.R. Inherited defects in the DNA glycosylase MYH cause multiple colorectal adenoma and carcinoma. Carcinogenesis 2003, 24:1281-1282.
20. Sakamoto K., Tominaga Y., Yamauchi K., Nakatsu Y., Sakumi K., Yoshiyama K., Egashira A., Kura S., Yao T., Tsuneyoshi M., Maki H., Nakabeppu Y., Tsuzuki T. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis. Cancer Res. 2007, 67:6599-6604.
21. Madhusudan S., Middleton M.R. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat. Rev. 2005, 31:603-617.
22. Helleday T., Petermann E., Lundin C., Hodgson B., Sharma R.A. DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer 2008, 8:193-204.
23. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., Nohmi T., Kasai H., Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
24. Shinmura K., Kohno T., Kasai H., Koda K., Sugimura H., Yokota J. Infrequent mutations of the hOGG1 gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn. J. Cancer Res. 1998, 89:825-828.
25. Kohno T., Kunitoh H., Toyama K., Yamamoto S., Kuchiba A., Saito D., Yanagitani N., Ishihara S., Saito R., Yokota J. Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. 2006, 97:724-728.
26. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
27. Arizono K., Osada Y., Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 2008, 38:186-191.
28. Hansen R., Saebo M., Skjelbred C.F., Nexo B.A., Hagen P.C., Bock G., Bowitz L., Johnson I.E., Aase S., Hansteen I.L., Vogel U., Kure E.H. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett. 2005, 229:85-91.
29. Sliwinski T., Krupa R., Wisniewska-Jarosinska M., Pawlowska E., Lech J., Chojnacki J., Blasiak J. Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population. Tohoku J. Exp. Med. 2009, 218:185-191.
30. Malins D.C., Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 1991, 51:5430-5432.
31. Olinski R., Zastawny T., Budzbon J., Skokowski J., Zegarski W., Dizdaroglu M. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 1992, 193:198.
32. Malins D.C., Holmes E.H., Polissar N.L., Gunselman S.J. The etiology of breast cancer: characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993, 71:3036-3043.
33. Jaruga P., Zastawny T.H., Skokowski J., Dizdaroglu M., Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 1994, 341:59-64.
34. Okamoto K., Toyokuni S., Uchida K., Ogawa O., Takenewa J., Kakehi Y., Kinoshita H., Hattori-Nakakuki Y., Hiai H., Yoshida O. Formation of 8-hydroxy-2'deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer 1994, 58:825-829.
35. Malins D.C., Polissar N.L., Gunselman S.J. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2557-2563.
36. Malins D.C., Polissar N.L., Gunselman S.J. Tumor progression to the metastatic state involves structural modifications in DNA markedly different from those associated with primary tumor formation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:14047-14052.
37. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995, 358:1-3.
38. Schmielau J., Finn O.J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 2001, 61:4756-4760.
39. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl. Cancer Inst. 2003, 95:1312-1319.
40. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol. Aspects Med. 2007, 28:258-275.
41. Mambo E., Chatterjee A., de Souza-Pinto N.C., Mayard S., Hogue B.A., Hoque M.O., Dizdaroglu M., Bohr V.A., Sidransky D. Oxidized guanine lesions and hOgg1 activity in lung cancer. Oncogene 2005, 24:4496-4508.
42. Schmid K., Nair J., Winde G., Velic I., Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int. J. Cancer 2000, 87:1-4.
43. Obtulowicz T., Winczura A., Speina E., Swoboda M., Janik J., Janowska B., Ciesla J.M., Kowalczyk P., Jawien A., Gackowski D., Banaszkiewicz Z., Krasnodebski I., Chaber A., Olinski R., Nair J., Bartsch H., Douki T., Cadet J., Tudek B. Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue of colon cancer patients. Free Radic. Biol. Med. 2010, 49:1064-1071.
44. Obtulowicz T., Swoboda M., Speina E., Gackowski D., Rozalski R., Siomek A., Janik J., Janowska B., Ciesla J.M., Jawien A., Banaszkiewicz Z., Guz J., Dziaman T., Szpila A., Olinski R., Tudek B. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients. Mutagenesis 2010, 25:463-471.
45. Birincioglu M., Jaruga P., Chowdhury G., Rodriguez H., Dizdaroglu M., Gates K.S. DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine). J. Am. Chem. Soc. 2003, 125:11607-11615.
46. Jaruga P., Theruvathu J., Dizdaroglu M., Brooks P.J. Complete release of (5'S)-8,5'-cyclo-2'-deoxyadenosine from dinucleotides, oligodeoxynucleotides and DNA, and direct comparison of its levels in cellular DNA with other oxidatively induced DNA lesions. Nucleic Acids Res. 2004, 32:e87.
47. Jaruga P., Kirkali G., Dizdaroglu M. Measurement of formamidopyrimidines in DNA. Free Radic. Biol. Med. 2008, 45:1601-1609.
48. Reddy P.T., Jaruga P., Nelson B.C., Lowenthal M., Dizdaroglu M. Stable isotope-labeling of DNA repair proteins, and their purification and characterization. Protein Expr. Purif. 2011, 78:94-101.
49. 15N-labeled analogs as internal standards. J. Proteome Res. 2011, 10:3802-3813.
50. Gackowski D., Speina E., Zielinska M., Kowalewski J., Rozalski R., Siomek A., Paciorek T., Tudek B., Olinski R. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res. 2003, 63:4899-4902.
51. Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat. Res. 2005, 591:45-59.
52. Dherin C., Radicella J.P., Dizdaroglu M., Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res. 1999, 27:4001-4007.
53. Audebert M., Radicella J.P., Dizdaroglu M. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the ogg1 protein. Nucleic Acids Res. 2000, 28:2672-2678.
54. Hazra T.K., Izumi T., Boldogh I., Imhoff B., Kow Y.W., Jaruga P., Dizdaroglu M., Mitra S. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3523-3528.
55. Jaruga P., Birincioglu M., Rosenquist T.A., Dizdaroglu M. Mouse NEIL1 protein is specific for excision of 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 4,6-diamino-5-formamidopyrimidine from oxidatively damaged DNA. Biochemistry 2004, 43:15909-15914.
56. Roy L.M., Jaruga P., Wood T.G., McCullough A.K., Dizdaroglu M., Lloyd R.S. Human polymorphic variants of the NEIL1 DNA glycosylase. J. Biol. Chem. 2007, 282:15790-15798.
57. Hu J., de Souza-Pinto N.C., Haraguchi K., Hogue B.A., Jaruga P., Greenberg M.M., Dizdaroglu M., Bohr V.A. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J. Biol. Chem. 2005, 280:40544-40551.
58. Chan M.K., Ocampo-Hafalla M.T., Vartanian V., Jaruga P., Kirkali G., Koenig K.L., Brown S., Lloyd R.S., Dizdaroglu M., Teebor G.W. Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst.) 2009, 8:786-794.
59. Muftuoglu M., de Souza-Pinto N.C., Dogan A., Aamann M., Stevnsner T., Rybanska I., Kirkali G., Dizdaroglu M., Bohr V.A. Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J. Biol. Chem. 2009, 284:9270-9279.
60. Dizdaroglu M., Dirksen M.L., Jiang H.X., Robbins J.H. Ionizing-radiation-induced damage in the DNA of cultured human cells. Identification of 8,5'-cyclo-2'-deoxyguanosine. Biochem. J. 1987, 241:929-932.
61. Brooks P.J., Wise D.S., Berry D.A., Kosmoski J.V., Smerdon M.J., Somers R.L., Mackie H., Spoonde A.Y., Ackerman E.J., Coleman K., Tarone R.E., Robbins J.H. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275:22355-22362.
62. Kuraoka I., Bender C., Romieu A., Cadet J., Wood R.D., Lindahl T. Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:3832-3837.
63. Jaruga P., Xiao Y., Vartanian V., Lloyd R.S., Dizdaroglu M. Evidence for the involvement of DNA repair enzyme NEIL1 in nucleotide excision repair of (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines. Biochemistry 2010, 49:1053-1055.
64. Kirkali G., de Souza-Pinto N.C., Jaruga P., Bohr V.A., Dizdaroglu M. Accumulation of (5'S)-8,5'-cyclo-2'-deoxyadenosine in organs of Cockayne syndrome complementation group B gene knockout mice. DNA Repair (Amst.) 2009, 8:274-278.
65. D'Errico M., Parlanti E., Teson M., Degan P., Lemma T., Calcagnile A., Iavarone I., Jaruga P., Ropolo M., Pedrini A.M., Orioli D., Frosina G., Zambruno G., Dizdaroglu M., Stefanini M., Dogliotti E. The role of CSA in the response to oxidative DNA damage in human cells. Oncogene 2007, 26:4336-4343.
66. Grollman A.P., Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 1993, 9:246-249.
67. Olivier M., Hollstein M., Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2010, 2:a001008.
68. - to misincorporate deoxyadenosine. J. Am. Chem. Soc. 2002, 124:7278-7679.
69. Kalam M.A., Haraguchi K., Chandani S., Loechler E.L., Moriya M., Greenberg M.M., Basu A.K. Genetic effects of oxidative DNA damages: comparative mutagenesis of the imidazole ring-opened formamidopyrimidines (Fapy lesions) and 8-oxo-purines in simian kidney cells. Nucleic Acids Res. 2006, 34:2305-2315.
70. Delaney M.O., Wiederholt C.J., Greenberg M.M. Fapy-dA induces nucleotide misincorporation tranlesionally by a DNA polymerase. Angew. Chem. Int. Ed. Engl. 2002, 41:771-775.
71. Birnbaum G.I., Cygler M., Dudycz L., Stolarski R., Shugar D. Comparison of solid state and solution conformations of R and S epimers of 8,5'-cycloadenosine and their relevance to some enzymatic reactions. Biochemistry 1981, 20:3294-3301.
72. Miaskiewicz K., Miller J.H., Fuciarelli A.F. Theoretical analysis of DNA intrastrand cross linking by formation of 8,5'-cyclodeoxyadenosine. Nucleic Acids Res. 1995, 23:515-521.
73. Marietta C., Brooks P.J. Transcriptional bypass of bulky DNA lesions causes new mutant RNA transcripts in human cells. EMBO Rep. 2007, 8:388-393.
74. Kuraoka I., Robins P., Masutani C., Hanaoka F., Gasparutto D., Cadet J., Wood R.D., Lindahl T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase η and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 2001, 276:49283-49288.
75. Marietta C., Gulam H., Brooks P.J. A single 8,5'-cyclo-2'-deoxyadenosine lesion in a TATA box prevents binding of the TATA binding protein and strongly reduces transcription in vivo. DNA Repair (Amst.) 2002, 1:967-975.
76. Brooks P.J. DNA repair in neural cells: basic science and clinical implications. Mutat. Res. 2002, 509:93-108.
77. Jasti V.P., Das R.S., Hilton B.A., Weerasooriya S., Zou Y., Basu A.K. (5'S)-8,5'-cyclo-2'-deoxyguanosine is a strong block to replication, a potent pol V-dependent mutagenic lesion, and is inefficiently repaired in Escherichia coli. Biochemistry 2011, 50:3862-3865.
78. Loeb L.A. Mutator phenotype in cancer: origin and consequences. Semin. Cancer Biol. 2010, 20:279-280.
79. Beckman R.A., Loeb L.A. Genetic instability in cancer: theory and experiment. Semin. Cancer Biol. 2005, 15:423-435.